Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia

NCT04255147 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
9
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ottawa Hospital Research Institute

Collaborators